The Afferent Pharmaceuticals brand, founded in 2009 (United States), from 402 sister brands and 17477 competing brands. Afferent Pharmaceuticals is a brand of Merck & Co, listed on the stock exchange of New York. Afferent Pharmaceuticals is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Merck & Co
(Afferent Pharmaceuticals)
over 5 years*
USD 219.35